United Therapeutics Corporation (UTHR): A Bull Case Theory
We found a bullish thesis on United Therapeutics Corporation in the BioEquity Watch Substack. In this article, we will summarize the bulls thesis on UTHR. Shares of United Therapeutics Corporation were trading at $471.99 on January 15. UTHR’s trailing and forward P/E were 17.89 and 15.15 respectively according to Yahoo Finance. science, laboratory, bioscience Phovoir/Shutterstock.com…